Prevalence of hepatitis B virus precore stop codon mutations in chronically infected children
- PMID: 16610027
- PMCID: PMC4087652
- DOI: 10.3748/wjg.v12.i14.2235
Prevalence of hepatitis B virus precore stop codon mutations in chronically infected children
Abstract
Aim: To find out whether there is a significant difference in the prevalence of the precore stop codon mutation between HBeAg positive and anti-HBe positive children.
Methods: We investigated a large pediatric population of 155 European children (mean age 10.9 years) with chronic hepatitis B by PCR and direct sequencing. Ninety were HBeAg positive and 65 had seroconversion to anti-HBe. Additionally genotyping was performed.
Results: Seventy-four (48%) of the sequenced HBV strains were attributed to genotype D and 81 (52%) to genotype A. In the group of 90 HBeAg positive patients, 2 (2.2%) 1896-G-to-A transitions leading to precore stop codon mutation were found, and in the group of 65 anti-HBe positive children, 5 (7.7%) were identified harbouring HBeAg-minus mutants. The difference was not statistically significant (P = 0.13).
Conclusions: HBeAg minus variants as predominant viral HB strains play a minor role in the course of chronic hepatitis B in European children.
Figures
References
-
- Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat. 2001;8:311–321. - PubMed
-
- Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991;324:1699–1704. - PubMed
-
- Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology. 1999;29:1252–1258. - PubMed
-
- Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M. Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay. J Clin Gastroenterol. 2004;38:460–464. - PubMed
-
- Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;2:588–591. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
